Raimar Loebenberg – författare

Novel Drug Delivery Systems in the Management of CNS Disorders offers a comprehensive source of information on delivering drugs to the central nervous system to treat various diseases and conditions. The book covers a wide range of CNS disorders, including epilepsy, Parkinson's, Alzheimer's, Huntington's, multiple sclerosis, schizophrenia, cerebral palsy, autism, ALS, and others.The book begins by presenting the foundations of drug delivery to the brain and addressing the associated challenges. It then delves into clinical trials and explores the future potential of the presented technologies.This reference is designed for drug delivery researchers in academia and corporations, providing them with the essential knowledge about overcoming the Brain-Blood Barrier and achieving targeted drug delivery to the central nervous system.

Consolidates current state of the art research into a single book volumePresents the challenges of drug delivery to the CNS in a comprehensive wayCovers the most relevant CNS conditions and diseasesProvides future perspectives and the most active research areas in this fast-moving field

Novel Drug Delivery Systems in the Management of CNS Disorders offers a comprehensive source of information on delivering drugs to the central nervous system to treat various diseases and conditions. The book covers a wide range of CNS disorders, including epilepsy, Parkinson''s, Alzheimer''s, Huntington''s, multiple sclerosis, schizophrenia, cerebral palsy, autism, ALS, and others.The book begins by presenting the foundations of drug delivery to the brain and addressing the associated challenges. It then delves into clinical trials and explores the future potential of the presented technologies.This reference is designed for drug delivery researchers in academia and corporations, providing them with the essential knowledge about overcoming the Brain-Blood Barrier and achieving targeted drug delivery to the central nervous system.- Consolidates current state of the art research into a single book volume- Presents the challenges of drug delivery to the CNS in a comprehensive way- Covers the most relevant CNS conditions and diseases- Provides future perspectives and the most active research areas in this fast-moving field

Advanced Drug Delivery Systems for Colonic Disorders presents state-of-the-art methods for targeted drug delivery to the colon. These methods can prolong drug half-lives, improve bioavailability, optimize pharmacokinetics, and reduce medication dosing frequency. Chapters allow readers to not only become familiar with advancements, but also understand concepts by providing illustrations, figures, and informative tables. Contents cover an overview of colonic diseases, the cellular and molecular mechanisms involved, current and traditional therapeutic approaches, biomaterials, oral drug delivery methods, targeted drug delivery, nutraceuticals and herbal medicine approaches, prebiotics, probiotics and symbiotics, nanomedicine approaches, and the status of clinical trials.This book is the perfect resources for researchers in pharma, biomaterials, and nutrition to help familiarize them with new and upcoming therapeutic methods. Research physicians in GI can also benefit from reading this book for its clinical applications.

Covers recent perspectives and challenges towards the treatment of colonic disordersProvides insights into how advanced drug delivery systems can be effectively used for the management of various types of colonic disordersDiscusses drug delivery strategies to manage inflammatory bowel disease (chronic inflammation in the digestive tract), ulcerative colitis (inflammation and ulcers in colon), Crohn's disease, Colonic polyps, Shigellosis, Colon Bleeding or Hemorrhage, Diverticulosis and colon cancer

Advanced Drug Delivery Systems for Colonic Disorders present the current state of the art methods for targeted drug delivery to the colon. These methods can prolong drug half-lives, improve bioavailability, optimize pharmacokinetics, and reduce medication dosing frequency.Chapters are written in a way that allows the audience to not only become familiar with the most recent advancement in the field, but to better understand them by referring to various illustrations, figures, and informative tables. The contents cover an overview of colonic diseases, the cellular and molecular mechanisms involved, current and traditional therapeutic approaches, biomaterials, oral drug delivery methods, targeted drug delivery, nutraceuticals and herbal medicine approaches, prebiotics, probiotics and symbiotics, nanomedicine approaches, and the current status of clinical trials in the area.Advanced Drug Delivery Systems for Colonic Disorders is the perfect resources for researchers in pharma, biomaterials, and nutrition to familiarize themselves with new and upcoming therapeutic methods. Research physicians in GI can also benefit from reading this book for its clinical applications. - Covers recent perspectives and challenges towards the treatment of colonic disorders- Provides insights into how advanced drug delivery systems can be effectively used for the management of various types of colonic disorders- Discusses drug delivery strategies to manage inflammatory bowel disease (chronic inflammation in the digestive tract), ulcerative colitis (inflammation and ulcers in colon), Crohn''s disease, Colonic polyps, Shigellosis, Colon Bleeding or Hemorrhage, Diverticulosis and colon cancer

Green Polymeric Materials in Drug Delivery: Sustainable Solutions for Therapeutic Applications addresses the critical intersection of polymer science, pharmaceutical technology, and environmental sustainability. This reference responds to the urgent need for eco-friendly drug delivery systems that improve therapeutic outcomes while minimizing ecological impact. It offers researchers and professionals a detailed exploration of green polymers derived from renewable sources and their transformative potential in healthcare. The comprehensive contents cover fundamental principles, synthesis, biocompatibility, formulation strategies, and innovative applications including nanomaterials, hydrogels, vesicular systems, and vaccine delivery. Chapters authored by leading experts examine targeted delivery routes such as mucosal, ocular, transdermal, and neural pathways. Regulatory frameworks and clinical trial insights further support translation from research to practice. Emerging technologies like AI-assisted formulation and 3D printing of implants are also discussed. This reference benefits polymer chemists, pharmaceutical scientists, regulatory experts, and clinicians by providing authoritative knowledge on sustainable materials for drug delivery. It equips readers with the scientific foundation and practical case studies necessary to advance green polymeric technologies in therapeutic development, fostering a sustainable future in pharmaceutical innovation and patient care.Explores diverse drug delivery strategies using sustainable polymersProvides comprehensive overview of green polymeric materials and their synthesisHighlights environmental benefits and reduced carbon footprintDiscusses regulatory considerations for clinical translationShowcases real-world case studies demonstrating therapeutic efficacy

This book examines the role of nanotechnology in transforming the diagnosis, treatment, and management of lung cancer. The initial chapters introduce lung cancer through its epidemiology, pathophysiology, and immunological mechanisms. The subsequent chapters emphasize the role of novel nanoparticles in early detection and imaging of lung cancer. The book then explores the potential of different nanomaterials, such as metal and metal oxide nanoparticles, nano micelles, carbon nanotubes, liposomes, polymeric nanoparticles, solid lipid nanoparticles, dendrimers, nanofibers, and quantum dots, in lung cancer treatment. Each chapter focuses on the unique properties from targeted drug delivery to improved bioavailability and reduced side effects. Exploring theragnostic nanoparticles, the book highlights their dual role in diagnosis and therapy, alongside nano-immunotherapy strategies for improved cancer treatment.The book concludes with a critical review of ongoing clinical trials, offering insights into the future of nanotechnology-based lung cancer therapies and emerging trends in the field.Key Features:Details the epidemiology and pathophysiology of lung cancer, covering disease prevalence, risk factors, and cellular mechanismsExamines the diagnostic capabilities of nanotechnology, emphasizing the use of nanoparticles in early detection and imagingExplores the therapeutic potential of various nanomaterials, such as liposomes, dendrimers, and quantum dots, for enhanced drug delivery and treatmentHighlights theranostic nanoparticles, combining diagnostic and therapeutic functions for personalized cancer careReviews clinical trials and emerging trends, providing insights into the future of nanotechnology-based lung cancer therapiesThe book is intended for researchers of oncology, nanomedicine, pharmaceutical sciences, and biomedical engineering.

This book examines the role of nanotechnology in transforming the diagnosis, treatment, and management of lung cancer. The initial chapters introduce lung cancer through its epidemiology, pathophysiology, and immunological mechanisms. The subsequent chapters emphasize the role of novel nanoparticles in early detection and imaging of lung cancer. The book then explores the potential of different nanomaterials, such as metal and metal oxide nanoparticles, nano micelles, carbon nanotubes, liposomes, polymeric nanoparticles, solid lipid nanoparticles, dendrimers, nanofibers, and quantum dots, in lung cancer treatment. Each chapter focuses on the unique properties from targeted drug delivery to improved bioavailability and reduced side effects. Exploring theragnostic nanoparticles, the book highlights their dual role in diagnosis and therapy, alongside nano-immunotherapy strategies for improved cancer treatment.

The book concludes with a critical review of ongoing clinical trials, offering insights into the future of nanotechnology-based lung cancer therapies and emerging trends in the field.

Key Features:

Details the epidemiology and pathophysiology of lung cancer, covering disease prevalence, risk factors, and cellular mechanisms Examines the diagnostic capabilities of nanotechnology, emphasizing the use of nanoparticles in early detection and imaging Explores the therapeutic potential of various nanomaterials, such as liposomes, dendrimers, and quantum dots, for enhanced drug delivery and treatment Highlights theranostic nanoparticles, combining diagnostic and therapeutic functions for personalized cancer care Reviews clinical trials and emerging trends, providing insights into the future of nanotechnology-based lung cancer therapies

The book is intended for researchers of oncology, nanomedicine, pharmaceutical sciences, and biomedical engineering.

This book examines the role of nanotechnology in transforming the diagnosis, treatment, and management of lung cancer. The initial chapters introduce lung cancer through its epidemiology, pathophysiology, and immunological mechanisms. The subsequent chapters emphasize the role of novel nanoparticles in early detection and imaging of lung cancer. The book then explores the potential of different nanomaterials, such as metal and metal oxide nanoparticles, nano micelles, carbon nanotubes, liposomes, polymeric nanoparticles, solid lipid nanoparticles, dendrimers, nanofibers, and quantum dots, in lung cancer treatment. Each chapter focuses on the unique properties from targeted drug delivery to improved bioavailability and reduced side effects. Exploring theragnostic nanoparticles, the book highlights their dual role in diagnosis and therapy, alongside nano-immunotherapy strategies for improved cancer treatment.

The book concludes with a critical review of ongoing clinical trials, offering insights into the future of nanotechnology-based lung cancer therapies and emerging trends in the field.

Key Features:

Details the epidemiology and pathophysiology of lung cancer, covering disease prevalence, risk factors, and cellular mechanisms Examines the diagnostic capabilities of nanotechnology, emphasizing the use of nanoparticles in early detection and imaging Explores the therapeutic potential of various nanomaterials, such as liposomes, dendrimers, and quantum dots, for enhanced drug delivery and treatment Highlights theranostic nanoparticles, combining diagnostic and therapeutic functions for personalized cancer care Reviews clinical trials and emerging trends, providing insights into the future of nanotechnology-based lung cancer therapies

The book is intended for researchers of oncology, nanomedicine, pharmaceutical sciences, and biomedical engineering.

This book comprehensively reviews the recent developments of natural polymers for drug delivery systems in various lung disorders. The initial chapter provides a brief introduction to lung diseases with a focus on the current landscape of natural polymers and trends in understanding the disease pathology. Several chapters of the book devoted to the latest technologies and advances in drug delivery systems include practical solutions on designing more effective drug delivery systems based on natural polymers that can be used in the management of lung diseases. Further, the book presents biodegradable and bio-reducible- natural polymers- based drug delivery systems for lung diseases. Towards the end, the book examines future prospects and challenges of natural polymers-based drug delivery systems in combating lung diseases. This book is useful for phytochemists, formulation/drug delivery, biological and translational researchers and clinicians working in the field of lung disorders.

This book comprehensively reviews the recent developments of natural polymers for drug delivery systems in various lung disorders. The initial chapter provides a brief introduction to lung diseases with a focus on the current landscape of natural polymers and trends in understanding the disease pathology. Several chapters of the book devoted to the latest technologies and advances in drug delivery systems include practical solutions on designing more effective drug delivery systems based on natural polymers that can be used in the management of lung diseases. Further, the book presents biodegradable and bio-reducible- natural polymers- based drug delivery systems for lung diseases. Towards the end, the book examines future prospects and challenges of natural polymers-based drug delivery systems in combating lung diseases. This book is useful for phytochemists, formulation/drug delivery, biological and translational researchers and clinicians working in the field of lung disorders.

The book comprehensively reviews and provides detailed insight into the cellular and molecular signalling mechanisms involved in pathophysiology of various respiratory diseases, towards developing effective therapeutic strategies in the management and treatment of lung disease. It also covers promising advances in the field of therapeutics that could lead to novel clinical therapies capable of preventing or reversing the disease features including novel strategies for targeting chronic lung diseases using advanced drug delivery systems. Importantly, the book examines the significance and relevance of the plant extracts and their constituents with therapeutic efficiencies against lung diseases. As such, the book offers a blend of translational, biological, chemical, and drug delivery aspects relevant to respiratory diseases, thus, offering a valuable resource for pulmonologists and translational researchers working in the field of pulmonary biology and respiratory medicine.